603963 Dali Pharmaceutical
- 2.08
- -0.11-5.02%
About Dali Pharmaceutical Company
The company was restructured and established in October 1996, and changed to a foreign-invested company limited by shares in January 2008. On September 22, 2017, the company's initial public offering of A-shares was officially listed on the main board of the Shanghai Stock Exchange. It became the first company listed on the A-share main board in Dali Prefecture and one of the few listed pharmaceutical companies in Yunnan Province. The company's main business is the production and sale of traditional Chinese medicine injections and the commercial distribution of pharmaceuticals. The company's main products are “Zhongjing” Xinming Injection and Shenmai Injection, and the “Zhongjing Zhongjing and Figure” trademark is a well-known trademark in China. Company honors include: Innovative Enterprises in Yunnan Province, Excellent Industrial Enterprises in Yunnan Province, Clean Production Enterprises, and Advanced Quality and Efficiency Enterprises in Yunnan Province.
Company Profile
Company Executives
- Name
- Position
- Salary
- junxiang yang
- Chairman, Directors, General Manager, Chairman of the Strategy Committee
- 583.30K
- cuixian yin
- Acting Chairman, Vice Chairman, Directors, Acting Chairman of the Strategy Committee
- 400.00K
- lihua ceng
- Vice Chairman, Directors, Strategy Committee Member, Audit Committee Member
- 240.00K
- jiyao ceng
- Directors, Member of the Remuneration and Assessment Committee
- 80.00K
- junwei yang
- Directors, Nomination Committee Members, Strategy Committee Member
- 236.50K
- wei yuan
- Directors, Strategy Committee Member
- 160.00K
- ronghui yao
- Independent Directors, Chairman of the Audit Committee, Nomination Committee Members
- 41.70K
- yulan li
- Independent Directors, Strategy Committee Member, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
- 41.70K
- quanliang dong
- Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Nomination Committee
- 100.00K
- peirong wu
- Board Secretary, Acting General Manager
- --
- liyao xu
- Securities Affairs Representative
- --
- xin liu
- Chairman of the Supervisory Board, Shareholder Supervisors
- 66.70K
- huaying xin
- Shareholder Supervisors
- 55.80K
- shaoyun li
- Deputy General Manager, Chief Financial Officer
- 347.70K
- zhuomei gao
- Employee Supervisors
- 36.00K
No Data
